![Rita Jain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rita Jain
Directeur/Membre du Conseil chez
SAB BIOTHERAPEUTICS, INC.
Fortune : 803 077 $ au 31/08/2026
Profil
Dr. Rita I.
Jain, MD, is an Independent Director at SAB Biotherapeutics, Inc., an Independent Director at Avalo Therapeutics, Inc., an Independent Director at Celldex Therapeutics, Inc. and an Independent Director at First Tracks Biotherapeutics, Inc. She is on the Board of Directors at SAB Biotherapeutics, Inc., Avalo Therapeutics, Inc., Celldex Therapeutics, Inc. and First Tracks Biotherapeutics, Inc. Dr. Jain was previously employed as an Independent Director by AnaptysBio, Inc., a Chief Medical Officer & Senior Vice President by Immunovant, Inc., a Member-Supervisory Board by AM-Pharma Holding BV, a Member-Supervisory Board by AM-Pharma BV, a Chief Medical Officer, Executive Director & EVP by ChemoCentryx, Inc., a Chief Medical Officer & Senior Vice President by Akebia Therapeutics, Inc., a Vice President-Health & Metabolic Development by AbbVie, Inc., a Vice President-Pharmaceutical Development by Abbott Laboratories, an Assistant Professor by New York University School of Medicine, and a Member by North Shore University Hospital.
She also served on the board at Provention Bio, Inc. She received her undergraduate degree from Long Island University and a doctorate degree from Stony Brook University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,06 % | 15/06/2026 | 19 194 ( 0,06 % ) | 803 077 $ | 31/08/2026 |
| 25/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 | |
| 30/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Rita Jain
| Sociétés | Poste | Début |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/02/2023 |
| AVALO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/06/2025 |
| SAB BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/01/2026 |
Anciens postes connus de Rita Jain
| Sociétés | Poste | Fin |
|---|---|---|
| ANAPTYSBIO, INC. | Directeur/Membre du Conseil | 20/04/2026 |
| PROVENTION BIO, INC. | Directeur/Membre du Conseil | 27/04/2023 |
| CHEMOCENTRYX, INC. | Directeur Technique/Scientifique/R&D | 20/10/2022 |
| IMMUNOVANT, INC. | Directeur Technique/Scientifique/R&D | 01/06/2021 |
| AKEBIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 17/06/2019 |
Formation de Rita Jain
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Health Technology |
North Shore University Hospital
 North Shore University Hospital Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stony Brook University School of Medicine
 Stony Brook University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
